UBS AM’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-64,369
| Closed | -$328K | – | 2862 |
|
|
2021
Q3 | $328K | Sell |
64,369
-480
| -0.7% | -$2.44K | ﹤0.01% | 2604 |
|
|
2021
Q2 | $410K | Buy |
64,849
+35,254
| +119% | +$223K | ﹤0.01% | 2591 |
|
|
2021
Q1 | $229K | Sell |
29,595
-19,776
| -40% | -$153K | ﹤0.01% | 2541 |
|
|
2020
Q4 | $323K | Hold |
49,371
| – | – | ﹤0.01% | 2399 |
|
|
2020
Q3 | $328K | Buy |
49,371
+18,440
| +60% | +$123K | ﹤0.01% | 2285 |
|
|
2020
Q2 | $258K | Buy |
30,931
+3,513
| +13% | +$29.3K | ﹤0.01% | 2330 |
|
|
2020
Q1 | $210K | Sell |
27,418
-7,165
| -21% | -$55K | ﹤0.01% | 2260 |
|
|
2019
Q4 | $287K | Sell |
34,583
-2,471
| -7% | -$20.5K | ﹤0.01% | 2381 |
|
|
2019
Q3 | $273K | Buy |
37,054
+8,490
| +30% | +$62.7K | ﹤0.01% | 2485 |
|
|
2019
Q2 | $320K | Buy |
28,564
+3,974
| +16% | +$44.6K | ﹤0.01% | 2391 |
|
|
2019
Q1 | $264K | Buy |
24,590
+11,590
| +89% | +$125K | ﹤0.01% | 2363 |
|
|
2018
Q4 | $196K | Hold |
13,000
| – | – | ﹤0.01% | 2398 |
|
|
2018
Q3 | $241K | Buy |
13,000
+900
| +7% | +$16.7K | ﹤0.01% | 2360 |
|
|
2018
Q2 | $277K | Buy |
+12,100
| New | +$277K | ﹤0.01% | 2340 |
|